Erratum: Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors.

Authors

Manish R Sharma, John Powderly, Yasutoshi Kuboki, John H Strickler, Ruth Perets, Jonathan E Cohen, Judith Raimboaurg, Takako Eguchi Nakajima, Noboru Yamamoto, Marcia Cruz-Correa, Bert O'Neil, François Ghiringhelli, Kanwal Raghav, Michael Cecchini, Jair Bar, Zoë Hunter, Michael Burns, Martha Blaney, Gladys Morrison-Thiele, Martha Neagu Aristide, Kevin J Freise, Rui Li, Martha Li, Athan Vasilopoulos, Carla Biesdorf, David Sommerhalder

Published in

Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Pages JCO2601401. Jun 15, 2026. Epub Jun 15, 2026.

PMID:
42296461
Bibliographic data and abstract were imported from PubMed on 16 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.